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ABSTRACT
Objective: 
To explore the barriers to warfarin use from the
perspective of nurses working in aged care.
Design: 
A qualitative study, involving a semi-structured
group interview, during March-April 2001.
Setting and Subjects: 
Eleven nurses, employed within the catchment of
the Northern Sydney Area Health Service, who were
involved in the care of elderly warfarinised patients.
Main outcome measure: 
Identification, via thematic analysis, of the main
themes underpinning the nursing perspective on
warfarin use in this setting, with regard to their
perceived role/s, experiences with patients, and
potential strategies for managing the therapy.
Results: 
Five main themes were identified: perceived patient
attitude toward warfarin; barriers to the use of warfarin;
expressed lack of confidence in the processes involved;
nurses’ role in warfarin use; and strategies to improve
warfarin use. Nurses were concerned about warfarin
use in the elderly, but felt they had a limited capacity
to intervene.
Conclusion: 
Nurses are potentially underutilised as a resource
and support for both patients and prescribers, in the
management of warfarin therapy.
INTRODUCTION
Nowadays, the professional role of nurses is quitediverse, ranging from patient care on the ward orin the community, through to specialist services
in the capacity of clinical consultants, specialists,
educators, and practitioners. However, there is one
clinical area, within Australian practice, that has not
utilised the nursing profession to its fullest potential:
anticoagulant therapy. 
Although nurses may work in anticoagulation clinics
or in post-acute care teams that liaise with anticoagulated
patients, the extent to which they engage with warfarin
therapy appears to be somewhat restricted and perhaps
superficial. This is unfortunate, as nurses maintain a
unique relationship with patients, which is unlike other
health professionals.
Internationally, there has been greater appreciation 
of the nurses’ role in this setting, including nurse-led
anticoagulation monitoring systems (Brown et al 1998;
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Connor et al 2002; Hennessy et al 1998; Taylor 
et al 1997), hospital-based nurse practitioner-led
anticoagulation services utilising computerised decision-
support systems (Vadher et al 1997), and nurse-led near
patient testing in GP surgeries (Fitzmaurice et al 1998).
Exploring the role of allied health professionals,
particularly nurses, in this clinical area has become
paramount as the number of patients requiring
anticoagulation, for common indications such as atrial
fibrillation (AF), is increasing. Despite pivotal evidence
to support the use of warfarin therapy in AF (Atrial
Fibrillation Investigators 1994; Hart et al 1999), several
Australian studies have demonstrated that, even in the
absence of apparent contraindications, warfarin therapy
remains underutilised (Ang et al 1998; Elliott et al 1999;
Stewart et al 1999), particularly in the target population of
elderly patients with AF (Bajorek et al 2002). One reason
for this suboptimal use includes a lack of support services
to assist both prescribers and elderly patients with the
initiation and subsequent management of this therapy.
AIM
In view of the recognised underutilisation of warfarin
therapy in the elderly, and lack of local support services,
the aim of this study was to explore the issues
surrounding the long-term use of warfarin in elderly
patients by examining, in depth, the unique perspectives
of nurses working in aged care. The specific objectives
were to: describe nurses’ experiences and attitudes toward
the use of warfarin in elderly patients; explore nurses’
perceptions regarding the risks and benefits of warfarin
therapy in elderly patients; identify any ‘barriers’ to 
the long-term use of warfarin as perceived and/or
experienced by nurses; and investigate nurses’ perceived
roles regarding warfarin therapy.
METHOD
Study Design
In this qualitative study, a group interview (focus
group) was conducted to draw upon attitudes, feelings,
beliefs, experiences and reactions in a way that would not
be feasible using observation, one-to-one interviewing, 
or questionnaire surveys alone (Morgan and Kreuger
1993). A semi-structured process was used where each
discussion was moderated by a facilitator, co-facilitator,
and scribe using a set of broad open-ended questions to
elicit the nurses’ experiences with warfarin, and their
opinions on how warfarin use could be optimised. These
questions reflected the pre-determined research objectives
and were pre-tested in mock interviews. 
Demographic data was collected separately using a
specifically designed questionnaire. Each session was
tape-recorded with additional note-taking by the scribe,
who also observed and noted any non-verbal behaviour
(facial expressions, body language, paralanguage etc) that
reinforced significant statements. 
Recruitment of Participants
Nurses involved in the inpatient and/or outpatient
management of elderly patients were recruited via study
flyers displayed in key locations around the project
hospital and larger community, including the: aged care
ward, community aged care assessment team, acute post-
acute care team that oversees the hospital-to-community
care of warfarinised patients, and community nursing
services. Additionally, information was conveyed during
weekly clinical meetings, departmental seminars, and
ward rounds. Sampling was opportunistic to capture 
the key nursing population, and purposive to find 
nurses willing to discuss their experiences; each was
screened upon enquiry, to ensure that they worked with
warfarinised elderly patients, by asking for a brief
description of their experiences. 
Participants provided their informed written consent to
take part and, to compensate for any losses incurred by
attendance (eg., time off during working hours, loss of
lunch hours, travel costs) all were offered a nominal
payment of $25.00, additional reimbursement of travel
expenses, and a light meal. The study was approved by
the institutional human research and ethics committee.
Data analysis
The audio-taped discussion was transcribed verbatim,
then manually analysed to identify emergent themes.
Thematic analysis breaks the text down (‘reduction’) into
defined units (words, statements) that are categorised 
into themes. A phenomenological approach was used,
focusing on understanding the essence of experiences
about a phenomenon via statements, meanings, themes,
and general descriptions of the experience (Husserl 1931;
Moustakas 1994).
To ensure the conclusions drawn from the analysis
were valid (ie. consistent with the actual content and
grounded in data) two of the investigators (acting as 
co-facilitator and scribe) observed the discussion and then
independently reviewed the transcripts to identify relevant
themes, issues and supporting statements, before jointly
discussing the findings to attain a consensus. The findings
were checked against the supplementary notes taken by
the scribe and also reviewed by the main facilitator, 




In total, 11 nurses working in aged care (all female),
representing each of the main nursing services
participated in the study; their mean age was 42.5 (+/-
10.4) years (range 25-54 years). Three nurses worked on
an aged care ward; two worked as aged care clinical nurse
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specialists/consultants; four worked for a home nursing
service; and two worked as hospital-to-community liaison
nurses. On average, the group had 18.9 (+/- 11) years
(range 3.5 - 33 years) professional experience working
with elderly warfarinised patients.
Perspectives of Nurses – Emergent themes
These nurses focussed on five main themes during the
group interview: Perceived patient attitudes towards
warfarin; Barriers to the use of warfarin; Expressed lack
of confidence in processes involved; Nurses’ role in
warfarin use; Strategies to improve warfarin use.
Theme 1: Perceived patient attitudes towards warfarin 
Nurses observed that patients’ involvement in their
warfarin therapy ranged from absolute dependence on
external direction and support, through to complete
engagement in the management processes. Some patients
appeared to become complacent toward warfarin after 
a period of time. Nurses believed that patients were
generally familiar with what type of medication warfarin
was (a ‘blood thinner’), although they did not always
understand why it was prescribed for them. 
It was perceived that patients’ knowledge of warfarin
was focused more on the practical aspects of dosing,
rather than the indication for use or associated risks.
Nurses also felt that most patients were also unfamiliar
with the actions to be taken when problems, such as
bleeding, arose.
We usually see them of a night-time as their dose is
adjusted and they say ‘why am I having two tablets
tonight and I had three tablets last night?’
They know what it is, but their usual difficulty is 
that they’ve had a bang to the skin and they can’t stop 
the bleeding. 
Some of them are actually monitoring —they take
down their international normalised ratio (INR) as well. 
There are often people too, who have been on it 
for donkey’s years following heart surgery…they are a 
bit lackadaisical. 
Nurses felt that patients overall were accepting of their
warfarin therapy, recognising its importance. Only a few
patients protested about it: ‘At times it is fairly clear they
don’t want to be on it.’ Day-to-day dosing issues, on a
background of poly-pharmacy and impaired memory,
were the perceived sources of disquiet and dissatisfaction
for many patients. 
Some patients talk about how they hate to take
medications per se, a number of tablets or…every day or
two times a day, it’s that kind of issue for them…not one
specific tablet…’Why do I have to take six this morning, I
only had to take five yesterday morning?’, as opposed to
what they are taking, it’s just the number they take. 
The nurses perceived that most patients were, however,
unperturbed about the risk of bleeding, even to the point
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Table 1: Perceived barriers to warfarin use
Functional patient barriers
The only thing that probably stands out like a sore thumb would be
somebody who had an excessively high fall risk. It might trigger a
few questions…
It’s one of those things that you always remember…patient in his
late 70’s…in the middle of the night had gotten out of bed…he
must have been going to the toilet…fallen down the stairs…bled 
to death.
Cognitive barriers
I’ve got a bit of a bee in my bonnet about cognition, unless 
they have a person who is a carer…I think it is risky, isn’t it? 
It is something that often gets overlooked in a hospital
situation…people present quite well but then are taken out 
of the confines of the hospital bed.
Poly-pharmacy
They start on warfarin…in hospital and they’ll come home and think
‘I’ve got a niggle in my knee, I’ll just take some [naproxen] or
[diclofenac]’ and they don’t realise the interactions.
A lot of the elderly are taking herbal supplements and things…they
don’t think they are drugs.
of ignoring precautionary measures, that is, until serious
adverse events occurred. Bruising was a commonly
registered complaint, albeit due to cosmetic reasons:
‘Some of the women they get those little bleeds under the
skin and they hate the disfigurement.’
According to nurses, patients felt powerless in terms of
the decision-making process and hence did not express
their dissatisfaction being on the therapy. It appeared 
to these nurses that patients rarely challenged health
professionals about being on warfarin therapy per se, but
rather queried dosing issues once a problem had arisen. It
was perceived that a good relationship with the general
practitioner (GP) was necessary to empower patients to
voice their concerns.
A lot of the older patients – ‘my doctor says it is good
for me so I’ll take it…they are an expert’…are pretty bad
because they don’t ask questions.
They just don’t voice a concern about taking it because
they don’t see they have any other option…just part of the
treatment that’s been prescribed…they have to put up
with it.
One patient…pretty responsible and tells the GP…he
rings up and gets his INR organised…he had a huge
bleed and actually challenged the doctors that he was on
too high a dose.
Theme 2: Barriers to the use of warfarin
Nurses described several sources of difficulty
regarding warfarin use (table 1). 
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The risk of falls was considered to be a major hazard
in the elderly, as well as functional and cognitive
impairment. Surprised and concerned, nurses also
described that they frequently saw patients who were
warfarinised despite some degree of cognitive impairment
and apparent memory problems. Intact cognition was
vital to safe warfarin use both in a practical sense and in
terms of successful patient education. 
Nurses expressed doubt about the ability of a patient to
cope with warfarin therapy in the home environment,
given the perception of poor in-patient assessment prior
to its initiation. Problems with cognition were not the
only factors they felt increased the risk of misadventure
with warfarin. INR control was affected by concomitant
medication use.
Theme 3: Expressed lack of confidence in processes
involved
Following from the earlier concerns, nurses expressed
that they were not confident about the processes involved
in initiating patients on warfarin, nor with the services
provided by other health professionals (table 2). 
Some nurses questioned whether clinicians adequately
considered some of the cognitive and functional barriers
to warfarin use in older patients. An over-burdened public
hospital system was perceived as the cause of
compromised assessment and preparation of elderly
patients, both in terms of education provision and
organising follow-up services.
Nurses also questioned the quality of education that
elderly patients received on the wards by pharmacists,
stating that more effort was needed in order to eliminate
unnecessary intrusions. Community pharmacists, who
were considered to be in the most opportune position for
ongoing education and counselling, were not perceived to
be a reliable ‘back-up’ system for these patients.
Much emphasis was placed, by these nurses, on the
role of the GP to adequately educate, monitor and follow-
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Table 2: Nurses expressed lack of confidence in processes
Lack of confidence in patient assessment processed regarding
warfarin initiation
I just wonder how much you would have an opportunity to
challenge…if the person has cognitive impairment or depending on
their home situation…how much that’s taken into consideration.
Quality of life, if they are 95 years of age, in a nursing home, they
are being stabbed every three days, they are probably going to have
a fall once a week, what are we doing for them?
The doctors all roll up at 9 o’clock in the morning to do their 
rounds — ‘yep they can go home…there are five other people 
down in A&E waiting to come up, let’s ship them down to transit
lounge.’ —they get home and open up this little plastic bag 
with all their drugs…pharmacist hasn’t had a chance to talk 
to them…we haven’t seen what they‘re on…pressure to get 
them out.
Patient Education
Education in the hospital ward…you are asking a lot when
somebody is in a four bedded room…[pharmacist] trying to 
explain something to you…you can’t hear, you can’t sleep very
well…probably not the best place for you to have all this stuff
explained to you…only so much we can do, it’s just too hectic.
How much education do the local chemists do? That is where 
these people go and get their drugs.
Follow-up in the community: GPs versus other services
If they have a good relationship and the GP takes…a bit of an
interest in the patient and the patient takes an interest in their own
health, then that works. But if you get a fall down in any of those
things…they don’t get monitored very well.
Less GPs do home visits…people have trodden off to medical
centres…interaction is more rushed.
We are in the link with the haematology department…they 
follow-up the patient…once a week to a fortnight . Do INRs 
every day or every second day and then they are discharged to 
their GP who will organise for an INR to be done…Or we liaise
directly with the GPs and do daily INRs and the GP will see a 
patient as soon as they are discharged…home visit or the patient
will see the GP.
Table 3: Nurses’ perceived roles in warfarin therapy
Level of current input within the hospital setting 
If it is written up I get it out and give it to them…God knows we
have enough to do without looking up these extra things like should
they be on warfarin.
I give out what is charted pretty much…the standard pink form, if it
needs charting we’ll look up the INR, write it down and write ‘would
doctors please chart it’…if you find out what the INR is and then
they just look at the little box…probably what we could very easily
do ourselves.
Level of current input within the community setting 
We don’t actually say to put them on warfarin…we only get them
when they are already on warfarin really…they continue. It’s more
about patient education.
We liaise with the GP on a daily basis and use the guidelines from
the hospital…for anticoagulation and we can’t say to the doctor —
‘this is what is recommended’…but we fax them the guidelines and
we try and persuade them to keep within those guidelines.
I had an incident over the weekend where a GP had prescribed a
large dose of warfarin for a lady who had been quite unwell. I
actually rang him, not challenged, but asked him was he sure that
was the dosage he wanted…‘perhaps we can do an INR sooner
rather than in three days, we could do one tomorrow’…we’ve got
an opportunity to work that closely with the doctors
Opportunity to intervene 
Generally the GPs and the hospital have made the decision if they
want to warfarinise the patient subsequent to heparinisation or
straight on to warfarin. As for us initiating it —no.
I have found that in the community there is generally more
opportunity for nurses to have that input…you get to liaise 
with the GP.
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up older patients, but the success of this process depended
on their relationship with the patient. These nurses,
however, believed that efficient support systems,
particularly for INR monitoring, were widely available
and catered to most patient situations.
Theme 4: Nurses’ role in warfarin use
Nurses agreed that, on the whole, they had little input
into the prescribing of warfarin for their patients (table 3). 
They were generally unaware of the indications, 
or the existence of guidelines, for warfarin use, albeit
recognising that more of their elderly patients were 
being prescribed it for AF. At the ward level, nursing
involvement was limited to prompting the doctors to
check INR results and dosage administration. 
Consistent with this focus on the practicalities of
warfarin use, nurses relied on ‘tools’ such as medication
charts and ‘the pink form that we use in the hospital that
gives you guidelines that gives you what dosages people
should be on’, to assist them in this. They maintained a
very patient-centred and pragmatic attitude toward their
role in this setting. Those who worked in the community
setting, particularly on a hospital-to-community liaison
basis, reported greater involvement due to increased
opportunities to liaise with GPs. However, their primary
commitment was still to ensuring appropriate patient care.
Although the nurses felt they were qualified to take a
greater role in monitoring and assessing patients, both in
acute and long-term care, they felt under-resourced within
their establishments to do this effectively. Furthermore,
these nurses did not desire a greater role in the use of
warfarin, as they felt this was the entirely the doctor’s
role. As far as they were concerned, the doctors were
responsible for making the decisions, whilst nurses were
responsible for ‘follow-up’. 
However, many nurses felt they were in a prime
position to identify patients who were having problems,
although they did not feel authorised or resourced enough
to address these needs adequately.
Occasionally patients are on contraindicated
medication and you pick up on it when you visit
them…and sometimes they double dip on the doctors as
well.[ie. see more than one doctor.] 
You need to be twice as vigilant when you are checking
the medications in the home situation…what’s there, 
what they are supposed to be taking as opposed to what
they might be taking.
Patients coming in on herbals usually have a whopping
great big bag full of them. They’ll have four medication
charts and the family will be insisting they stay on
them…and the poor patient is saying, ‘I don’t want that
many, I’m sick of having them, I don’t want it.’ And you
think, ‘if it was up to me love, I’d just chuck them all in 
the bin.’
Theme 5: Strategies to improve warfarin use
To assist warfarin use in the elderly, nurses felt more
could be done in the way of education. In particular, more
effort was required in getting patients to refer to the
warfarin booklets for advice. They felt it was also crucial
to encourage patients and their carers to take a more
active role in their own therapy. 
Prompt people to have [INRs] done…[to be] aware of
the side-effects of warfarin and the risk of injury or
bleeds, but they need to be educated in this way.
One of the things that I often tell the patient, is that
you are responsible, nobody else is, for your blood tests
and everything…it will make them remember.
Given that ‘education is useful for people who can
understand and who can carry out instructions, but
education is useless for people with dementia…even if
you educate them, they forget’, nurses felt that a greater
utilisation of carer support and services was vital. The
perceived role of carers, whether the patient’s relatives or
professional agents, ranged from the simple tasks of
dosage administration to ongoing patient surveillance. It
was felt that performing home visits to patients was
particularly important in terms of patient surveillance. 
A lot of them need the help of some nurses actually to
go in…and give the pills…even with the [blister] pack a
lot of elderly people have no idea how to press the tablet
out…home nurses have to go in just to press the tablet out
for the client.
Sometimes their partner, the same age, is half
demented and doesn’t really know what is going on. They
can’t see or they can’t understand so a community home
nurse can actually monitor the blood test and then the
dosage…they play a very important role in doing that.
Others believed that there needed to be a more
thorough assessment of older patients prior to discharge,
particularly with respect to cognition, in order to ascertain
their ability to cope with warfarin at home.
Guidelines…if someone does have a cognitive
problem, that they actually be investigated, if they live
alone, to see that they are okay to be put on warfarin and
are there any other options. 
We had a self-administering program trial that 
was running down there in terms of medications…‘Going
home? Let’s start getting them self-administering with
supervision in the ward. Can they read the chart 
first? Have they got spectacles that are new? Do they
understand what is going on?’ And if they are doing it
right for a week in hospital, then I would feel comfortable
sending them home. I think that is something that could
be trialled.
DISCUSSION
Although previous studies have explored the
perspectives of prescribers (Lip et al 1996; McCrory et al
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1995; Peterson et al 2002), none have probed further to
identify the experiences and perceptions of allied health
professionals regarding the use of warfarin in the elderly
population. This is the first known study to have
examined the perspectives of nurses in this setting.
Overall, nurses in this study appeared to be quite
fearful of warfarin, expressing hesitation and concern
about their patients being warfarinised. This in part
reflected their expressed lack of awareness regarding the
specific indications for warfarin therapy, and in part their
acute awareness of the difficulties associated with its use
in the elderly, given their level of patient contact. Those
who had extensive opportunity to assess patients’ abilities
in activities of daily living most explicitly stated that the
risk of misadventure with warfarin increased with age-
related frailty, functional and cognitive impairment, a
predisposition to falls, potential non-compliance, poly-
pharmacy, and a general lack of education. Nurses
expressed doubt as to how well these factors were
assessed or addressed by prescribers when warfarin
therapy was initiated.
Despite their concerns about the decision-making
processes regarding initiating warfarin in any patient,
nurses generally believed that they had no role here. 
They conceded that this responsibility was entirely the
prescriber’s, and if nurses had any involvement at all, it
was merely to confirm the prescriber’s intentions if there
was any doubt. 
Community based nurses had some involvement in 
the short term follow-up of patients for blood testing 
and dosage adjustment, while hospital based nurses 
stated they simply administered prescribed doses, after
reminding doctors to chart these. They were motivated to
intervene only when they felt warfarin should be ceased,
so cessation rather than treatment initiation was their
focus. This was further compounded by their lack of
awareness of the specific indications for therapy, such as
stroke prophylaxis in atrial fibrillation. 
Although nurses entirely relied on prescribers to
appropriately manage the patient over the long term with
respect to routine INR testing, subsequent dosage
titration, and pharmacovigilance, they expressed doubt as
to how well doctors were doing this. They felt the current
nature of health care, both within the hospital and
community settings, was not conducive to detailed and
individualised patient care, as seen to be necessary here.
Consequently, nurses felt the barriers to warfarin use
included not only the patient-related characteristics, but
also the lack of support services in the community to
assist patients. They themselves felt prescribers could
make greater use of existing allied health services (nurses
and pharmacists), particularly within the community. 
Unlike previous studies, this research acknowledges
that the use of warfarin involves players other than just
the prescriber and patient. Nurses are often the interface
for medication-related problems, and as such should 
also play an important role in the administration and
monitoring of warfarin therapy. This is often overlooked,
but is pertinent in view of anecdotal requests for
increasing the role of allied health care professionals.
Acknowledging that many individuals are involved is a
prerequisite for understanding that there are a multiplicity
of perceptions and experiences relating to warfarin use.
LIMITATIONS OF THE STUDY
As in all qualitative studies, the researcher has less
control over data collection since participants must be
allowed to interact with each other. In some cases an
emerging ‘group culture’ may interfere with individual
expression and then ‘group-think’ occurs (Frey and
Fontana 1994). Therefore, there may be some uncertainty
as to whether the identified themes actually describe the
participants’ true opinions (Krueger 1997). 
Further, participants may have been ‘steered’ into
particular points of view if they felt any of the researchers
maintained ‘strong ideological predispositions’. However,
careful planning and moderation of the focus groups
should have prevented this. The ability to generalise 
in relation to these findings for a whole population may
be limited by the small numbers of nurses involved 
in this study, which may not represent the wider 
nursing profession. 
CONCLUSION
Overall, nurses currently maintain a limited role in the
anticoagulant therapy of elderly patients. In view of the
many difficulties associated with warfarin use, such as
patient characteristics, as well as the expressed lack of
confidence in prescribing processes, there is scope for
nurses to be more involved in decision making processes,
for both long term monitoring and management, and to
assist prescribers and patients.
Recommendations for practice
The limited engagement of nurses in this clinical area
is surprising and somewhat disappointing. Further
education to increase nurses’ knowledge about warfarin
therapy, and pharmacology in general, as well as the
development and implementation of multidisciplinary
interventions involving nurses to ensure appropriate
hospital-based prescribing and post-discharge management,
is needed. Encouragement of nurses to take on more 
pro-active roles in this area is also warranted.
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